These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7577339)

  • 41. Retrovirus mediated gene transfer as therapy for adenosine deaminase (ADA) deficiency.
    Ramsey WJ; Mullen CA; Blaese RM
    Leukemia; 1995 Oct; 9 Suppl 1():S70. PubMed ID: 7475319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of gene therapy for immunodeficiency: adenosine deaminase deficiency.
    Blaese RM
    Pediatr Res; 1993 Jan; 33(1 Suppl):S49-53; discussion S53-5. PubMed ID: 8433875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Harmful potential of viral vectors fuels doubts over gene therapy.
    Check E
    Nature; 2003 Jun; 423(6940):573-4. PubMed ID: 12789298
    [No Abstract]   [Full Text] [Related]  

  • 44. Stem-cell treatment brings a historic week in gene therapy.
    Jenks S
    J Natl Cancer Inst; 1993 Jun; 85(12):944-6. PubMed ID: 8496979
    [No Abstract]   [Full Text] [Related]  

  • 45. Steps toward gene therapy: 1. The initial trials.
    Blaese RM
    Hosp Pract (1995); 1995 Nov; 30(11):33-40. PubMed ID: 8557801
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gene therapy for ADA-SCID, the first marketing approval of an
    Aiuti A; Roncarolo MG; Naldini L
    EMBO Mol Med; 2017 Jun; 9(6):737-740. PubMed ID: 28396566
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bone marrow transplantation and alternatives for adenosine deaminase deficiency.
    Gaspar HB
    Immunol Allergy Clin North Am; 2010 May; 30(2):221-36. PubMed ID: 20493398
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phoenix rising: gene therapy makes a comeback.
    Limberis MP
    Acta Biochim Biophys Sin (Shanghai); 2012 Aug; 44(8):632-40. PubMed ID: 22623503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene therapy in the treatment of disease.
    Dickler HB; Collier E
    J Allergy Clin Immunol; 1994 Dec; 94(6 Pt 1):942-51. PubMed ID: 7798542
    [No Abstract]   [Full Text] [Related]  

  • 50. Recollections from a Pioneer Who Provided the Foundation for the Success of Gene Therapy in Treating Severe Combined Immune Deficiencies.
    Wilson JM
    Hum Gene Ther Clin Dev; 2016 Jun; 27(2):53-6. PubMed ID: 27314911
    [No Abstract]   [Full Text] [Related]  

  • 51. Good Laboratory Practice Preclinical Safety Studies for GSK2696273 (MLV Vector-Based Ex Vivo Gene Therapy for Adenosine Deaminase Deficiency Severe Combined Immunodeficiency) in NSG Mice.
    Carriglio N; Klapwijk J; Hernandez RJ; Vezzoli M; Chanut F; Lowe R; Draghici E; Nord M; Albertini P; Cristofori P; Richards J; Staton H; Appleby J; Aiuti A; Sauer AV
    Hum Gene Ther Clin Dev; 2017 Mar; 28(1):17-27. PubMed ID: 28319446
    [TBL] [Abstract][Full Text] [Related]  

  • 52. At age 2, gene therapy enters a growth phase.
    Thompson L
    Science; 1992 Oct; 258(5083):744-6. PubMed ID: 1472258
    [No Abstract]   [Full Text] [Related]  

  • 53. Improved retroviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor.
    Dunbar CE; Seidel NE; Doren S; Sellers S; Cline AP; Metzger ME; Agricola BA; Donahue RE; Bodine DM
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11871-6. PubMed ID: 8876230
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fetal somatic gene therapy.
    Douar AM; Themis M; Coutelle C
    Mol Hum Reprod; 1996 Sep; 2(9):633-41. PubMed ID: 9239676
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gene transfer into hematopoietic stem cells: prospects for human gene therapy.
    Einerhand MP; Valerio D
    Curr Top Microbiol Immunol; 1992; 177():217-35. PubMed ID: 1353431
    [No Abstract]   [Full Text] [Related]  

  • 56. Progress in genetic therapy for severe combined immunodeficiency associated with adenosine deaminase deficiency.
    Williams DA
    Mol Ther; 2009 Apr; 17(4):577-8. PubMed ID: 19337228
    [No Abstract]   [Full Text] [Related]  

  • 57. RAC confronts in utero gene therapy proposals.
    Couzin J
    Science; 1998 Oct; 282(5386):27. PubMed ID: 9786789
    [No Abstract]   [Full Text] [Related]  

  • 58. [Severe combined immunodeficiency diseases].
    Tsuchiya S
    Nihon Rinsho; 2005 May; 63 Suppl 5():565-9. PubMed ID: 15954410
    [No Abstract]   [Full Text] [Related]  

  • 59. A small step for gene therapy.
    Nat Genet; 1994 Apr; 6(4):323-4. PubMed ID: 8054965
    [No Abstract]   [Full Text] [Related]  

  • 60. PEG-ADA: an alternative to haploidentical bone marrow transplantation and an adjunct to gene therapy for adenosine deaminase deficiency.
    Hershfield MS
    Hum Mutat; 1995; 5(2):107-12. PubMed ID: 7749407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.